Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging

Area of Science:

• Neurology
• Nuclear Medicine
• Movement Disorders

Background:

• Presynaptic dopamine imaging is crucial for differentiating degenerative parkinsonism from non-degenerative movement disorders.
• Some early Parkinson's disease (PD) cases present with normal dopamine imaging, necessitating long-term follow-up.
• Distinguishing between false-negative imaging and over-diagnosis of PD is essential.

Purpose of the Study:

• To evaluate the long-term clinical outcomes of patients with normal presynaptic dopamine imaging (I-FP-CIT SPECT).
• To determine if normal imaging in suspected parkinsonism predicts a non-degenerative condition.
• To assess the diagnostic accuracy of dopamine imaging in early-stage movement disorders.

Main Methods:

• Retrospective review of 150 patients with normal I-FP-CIT SPECT scans over a 3-year period.
• Follow-up assessment of clinical progression and diagnosis an average of 2.4 years post-SPECT.
• Analysis of anti-Parkinson therapy use and response in relation to diagnostic criteria.

Main Results:

• 146 out of 150 (97%) patients with normal imaging were diagnosed with non-degenerative parkinsonism or tremor, showing no clinical progression.
• Only 4 patients (3%) showed signs of degenerative parkinsonism upon follow-up.
• Anti-Parkinson therapy was initiated in 36 patients, with 25 tolerating withdrawal without deterioration.

Conclusions:

• Normal presynaptic dopamine imaging strongly supports a non-degenerative movement disorder diagnosis in most cases.
• Long-term follow-up confirms the high predictive value of normal dopamine imaging for benign conditions.
• Clinical assessment and imaging findings should be integrated for accurate diagnosis of movement disorders.